People

Mina Kim
Mina Kim is Capsida’s executive chair. She previously led Acelyrin as CEO and chief legal/administrative officer and held corporate-development and legal leadership at Zymergen and Atara. She holds a Harvard JD and Dartmouth history BA.
Roles
Capsida Biotherapeutics
CurrentExecutive Chair
Capsida Biotherapeutics
CurrentInterim Chief Executive Officer (May2026 announcement)